APP and Alzheimer disease: Since the expression of C3 was drastically increased in Aβ-seeded mice and upregulated astrocytic C3 expression was previously observed in AD patients (Liddelow et al., 2017), as well as in APP transgenic mice (Lian et al., 2016), we determined C3 levels via immunofluorescence staining.